Brightonix Imaging Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Brightonix Imaging Inc. - overview
Established
2016
Location
Seoul, -, South Korea
Primary Industry
Healthcare IT
About
Based in Seoul, South Korea, and founded in 2016, Brightonix Imaging Inc. , a. k. a.
Brightonix Imaging operates as a healthcare IT company that intends to provide AI-based PET analysis software and brain PET (Positron Emission Tomography) (positron tomography) solutions. In May 2022, Brightonix Imaging Inc. raised KRW 6 billion in a Series A funding from Hana Ventures and T. S.
Investment. As of May 2022, Lee Jae-sung is the CEO of the company. The company provides automated quantification software for amyloid-β PET, tau PET, dopamine transporter PET, and FDG PET. Brightonix Imaging also offers clinical devices, such as brain-dedicated PET, as well as preclinical devices, such as SiPM-based small animal PET systems for hybrid imaging and standalone use.
Current Investors
T.S. Investment, Hana Ventures, KNet Investment Partners
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Medical Devices & Equipment, Pharmaceutical Research & Development
Website
www.brtnx.com
Verticals
Artificial Intelligence, HealthTech, Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.